We are pleased to announce the release of an updated version of the Simulacrum containing two additional years of diagnostic data (2013 – 2017 diagnoses) and treatment follow up to March 2018.
This new version of the Simulacrum contains almost twice as many synthetic patients as the previous version and over 900,000 new tumours. The vital status of each synthetic patient is now simulated up to February 2019.
The data dictionary for this release (version 1.2017) is the same as the previous release. To download the new version, go to the download page.
| Simulacrum v1.2.0 | Simulacrum v2.1.0 | |
| Diagnosis years | 2013-2017 | 2016-2019 |
| Synthetic patients | 2,200,626 | 1,871,605 |
| Synthetic tumours | 2,371,281 | 1,995,570 |
| Synthetic patients with SACT | 366,266 | 352,372 |
| Synthetic patients with RTDS | -- | 413,169 |
| Synthetic patients with genomic testing data | -- | 94,908 |
| Years of SACT data | 2012 onwards | 2012-2022 |
| Years of RTDS data | -- | 2012-2022 |
| Years of genomics data | -- | 2016-2019 |
| SACT regimens | 730,472 | 781,389 |
| SACT cycles | 2,442,037 | 2,741,674 |
| SACT drug administrations | 6,385,828 | 7,662,030 |
| RTDS episodes | -- | 656,560 |
| RTDS prescriptions | -- | 657,648 |
| RTDS exposures | -- | 13,201,531 |
| Genomic tests | -- | 255,728 |
| Non-melanoma skin cancer diagnoses (C44) | 607,619 | 514,517 |
| Breast cancer diagnoses (C50) | 226,406 | 187,204 |
| Prostate cancer diagnoses (C61) | 201,785 | 179,478 |
| Lung cancer diagnoses (C34) | 169,118 | 156,927 |